Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our mission is to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
Follow our daily press programme live during ESC Congress 2016.
Chairpersons: J Perk (Oskarshamn, SE) - M F Piepoli (Piacenza, IT)
Chairpersons: G Hindricks (Leipzig, DE) - F Schiele (Besancon, FR)
Chairpersons: M Jessup (Philadelphia, US) - F Ruschitzka (Zurich, CH)
Chairpersons: J Belardi (Buenos Aires, AR) - S Gielen (Detmold, DE)
Chairpersons: K Swedberg (Goteborg, SE) - M Komajda (Paris, FR)
Increasing readmissions to hospital worsen mortality and decrease survival in Heart Failure patients - 15 year study from the United Kingdom from 2000-2014
Chairpersons: J Brugada Terradellas (Barcelona, ES) - K Huber (Vienna, AT)
Chairpersons: DE Grobbee (Utrecht, NL) - J Perk (Oskarshamn, SE)
Chairpersons: M Haude (Neuss, DE) - F J Pinto (Lisbon, PT)
Importance of team work, interactions between specialties, and institutions in managing CVD: focus on Prevention and Congenital Heart Disease
Presenters: R.Ferrari / F. Romeo / F. Cognetti
Chairpersons: S D Kristensen (Aarhus N, DK) - A Baumbach (Bristol, GB)
Chairpersons: M A Creager (Lebanon, US) - J Perk (Oskarshamn, SE)
ENSURE-AF study: Edoxaban for cardioversion of atrial fibrillation
ANNEXA-4 - Andexanet alfa for reversal of Factor Xa inhibitors in patients with acute major bleeding
REVERSE II - Multi-national validation of the men continue and HERDOO2 rule to identify low risk unprovoked venous thromboembolism patients who can discontinue anticoagulants
YEARS - Safety and efficiency of a simplified diagnostic management algorithm for 3500 patients with clinically suspected acute pulmonary embolism
Guidelines released on Saturday 27 August 8:30 CEST
ESC Press Office For background information, please contact the ESC Press Office at firstname.lastname@example.org.
For press enquiries, please contact, the Media & Press Coordinator, Jacques Olivier Costa: +393427028575
For independent comment on site, please contact the ESC Spokesperson coordinator, Celine Colas: +393402405148
The press conference timetable is available here.
To access all the scientific resources from the sessions during the congress, visit ESC Congress 365.
About the European Society of Cardiology
The European Society of Cardiology brings together health care professionals from more than 120 countries, working to advance cardiovascular medicine and help people lead longer, healthier lives.
About ESC Congress 2016
ESC Congress is the world’s largest gathering of cardiovascular professionals contributing to global awareness of the latest clinical trials and breakthrough discoveries. ESC Congress 2016 takes place 27 to 31 August at the Fiera di Roma in Rome, Italy. The scientific programme is here. More information is available from the ESC Press Office at email@example.com
© 2017 European Society of Cardiology. All rights reserved